Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

• Status: Completed
• Trial end date: 2004-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the duration of the treatment with alendronate in postmenopausal women with osteoporosis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ciudad Universitaria, Spain
• Treatments: Alendronate

Criteria

Inclusion Criteria:

• postmenopausal osteoporosis under densitometric criteria of the World Health Organization

Exclusion Criteria:

• secondary osteoporosis

• alteration in analytic parameters (total proteins, calcium, phosphorus, vitamin D, parathyroid hormone, thyroid hormone, transaminase, creatinine)